A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia

By this time, multiple vaccines have been approved to limit the spread of SARS-CoV-2 worldwide. These include new-generation vaccines that contain mRNA of the target organism. Some common side effects were identified and reported during phase 3 clinical trials of vaccination, but more rare adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaydev, Fnu, Kumar, Vinod, Khatri, Jaikumar, Shahani, Shobha, Beganovic, Sead
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799952/
https://www.ncbi.nlm.nih.gov/pubmed/35103106
http://dx.doi.org/10.1155/2022/2036460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799952/
https://www.ncbi.nlm.nih.gov/pubmed/35103106
http://dx.doi.org/10.1155/2022/2036460

Ejemplares similares